Intralesional Bleomycin Sclerotherapy

Results of Ultrasonography-guided Intralesional Bleomycin Sclerotherapy for Treatment of Macrocystic Lymphangioma in Children and Comparison with traditional surgical methods

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150114020663N5

Enrollment

Registered

2021-09-13

Start date

2021-09-23

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphangioma. Lymphangioma, any site

Interventions

Intervention 1: Intervention group: Intralesional Bleomycin Sclerotherapy: In patients in this group, injections are performed by one person and under ultrasound guide in the operating room and under

Eligibility

Sex/Gender

All

Age

1 Days to 14 Years

Inclusion criteria

Inclusion criteria: Cysts in the lymphatic system in different parts of the body: entry Parental consent: entry

Exclusion criteria

Exclusion criteria: Lymphangioma with small cysts Previous surgery

Design outcomes

Primary

Measure	Time frame
Recurrence of lymphangioma. Timepoint: 6 month. Method of measurement: Sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDavoud Badebarin

Tabriz University of Medical Sciences

badebarind@tbzmed.ac.ir+98 41 3325 2272

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026